Private Equity Deal Spotlight | Weekly Update

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

• Forcura and Medalogix have completed a merger in which Berkshire Partners will serve as the lead investor of the new platform. Forcura, a health care software-as-a-service company, merged with Medalogix, a hospice data analytics company. The combined entity will allow providers to utilize one platform to streamline patient care transitions, optimize resource allocation and improve end-of-life care management. As lead investor, Berkshire Partners hopes to accelerate technological growth and innovation while delivering premium care to customers. Berkshire Partners is a Boston, Massachusetts-based PE firm with over $16 billion in capital commitments.
• Advanced Instruments, a subsidiary of Patricia Industries, merged with Nova Biomedical, a provider of analytical instruments and consumables for the global biopharmaceutical and clinical research sectors. Advanced Instruments provides analytical instruments for the biotech and clinical research sectors. The combined entity will operate under the Nova Biomedical name and will seek to support biotech and clinical companies developing new drugs. Patricia Industries is a PE firm based in Stockholm, Sweden and New York City that specializes in health care industry investments.
• Knox Lane announced a strategic investment in Healthcare Experts Squared (“HCEsquared”). HCEsquared is a management platform currently focused on the dermatology sector, including medical education to keep dermatologists informed on the latest diagnoses and treatments. HCEsquared plans to use Knox Lane’s capital to grow across new services, geographic markets and medical specialties. Knox Lane is a PE firm headquartered in San Francisco, California with $2.6 billion of assets under management.
• AIM Equity Partners made a majority-control growth investment in AMOpportunities, a health care training platform. AMOpportunities develops personalized workforce recruitment strategies by partnering with health care schools in an effort to help address health care provider shortages. AIM Equity’s investment enables AMOpportunities to expand its platform into new medical specialties and to provide further value to its current clients. AIM Equity Partners is a Los Angeles-based PE firm focused on investments in niche technologies.

For questions or additional information on private equity matters, please contact: